Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr₹1,091 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹419 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr
Mar2021₹1,218 Cr
Mar2020₹1,091 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr
-24.36
Mar2021 ₹1,218 Cr
11.66
Mar2020 ₹1,091 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,729.9 Cr 1.9% 4.8% 41.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,818.0 Cr -3.3% 3.4% 13.9% Stock Analytics
DIVIS LABORATORIES ₹164,628.0 Cr 4.1% 15.2% 60.2% Stock Analytics
CIPLA ₹120,775.0 Cr 0.6% 5.6% 11.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,758.0 Cr 1.9% 3.7% 28.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,791.0 Cr 6.2% 11.4% 2.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.9%

4.8%

41.7%

SENSEX

0.7%

9.6%

10.7%


You may also like the below Video Courses